The US Bankruptcy Court gave an order approving the sale of certain assets of OncoSec Medical Incorporated on August 9, 2023. The debtor has been authorized to sell its certain assets through auction. Tiger Liquidity Services Biopharma Partners is acting as consultant for the sale.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | 0.00% |
2023 | Motion for Asset Sale Approved for OncoSec Medical Incorporated | CI |
2023 | Motion for Asset Sale Filed by OncoSec Medical Incorporated | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.19K | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ONCSQ Stock
- News OncoSec Medical Incorporated
- Motion for Asset Sale Approved for OncoSec Medical Incorporated